GENE EDITING JUST LEARNED TO MOVE BIGGER PIECES OF DNA.
A new lab method can place gene-sized DNA at targeted sites in human cells. No patients yet.
THE LAB HAD A GOOD DAY
A new genome-editing approach called prime assembly gives researchers a way to install medium-to-large DNA changes at targeted sites in human cells, including cells that are not dividing.
WHAT HAPPENED
Published in Nature on September 16, prime assembly uses CRISPR-targeted dual-flap synthesis to assemble and integrate DNA fragments at chosen genomic sites. The researchers demonstrated exon recoding, transgene integration and very large genomic rearrangements, including at therapeutically relevant loci in primary human cells. This is still laboratory work: it has not been shown to be a safe or effective treatment in people, and delivery, efficiency and off-target effects remain practical hurdles.
WHY THIS IS HOPESLOP
The useful part is not another “gene editing will cure everything” headline. It is that the toolbox can now handle kinds of edits that were awkward or difficult before. Bigger genomic repairs became more programmable — still in the lab, but measurably so.
ORIGINAL SOURCENatureRead the original report